CSCO NASDAQ CSCO Cisco Systems

Hot Movers: Cisco Systems (NASDAQ:CSCO), Pfizer Inc. (NYSE:PFE), World Wrestling Entertainment (NYSE:WWE), J.C. Penney Company (NYSE:JCP), Verizon Communications Inc. (NYSE:VZ)

Cisco Systems, Inc. (NASDAQ:CSCO) recently named Marco Inc. its 2013 Central Area Small to Medium Business Partner of the Year for leadership in implementing unified communications and cloud networking systems among other Cisco Systems, Inc. (NASDAQ:CSCO) technologies. Cisco Systems, Inc. (NASDAQ:CSCO) stock performance was 0.79% in last session and finished the day at $24.37. Traded volume was 40.48million shares in the last session and the … Continue reading Hot Movers: Cisco Systems (NASDAQ:CSCO), Pfizer Inc. (NYSE:PFE), World Wrestling Entertainment (NYSE:WWE), J.C. Penney Company (NYSE:JCP), Verizon Communications Inc. (NYSE:VZ)

Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Pfizer Inc. (NYSE:PFE)’s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses, but promised to keep key research jobs in Britain as part of its $106 billion takeover bid. Pfizer Inc. (NYSE:PFE) stock performance was 0.24% in last session and finished the day at $29.20. Traded volume was 26.29million shares in the last session and the average volume of … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Investor’s Alert: American International Group Inc (NYSE:AIG), General Electric Company (NYSE:GE), Petroleo Brasileiro Petrobras (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

American International Group Inc (NYSE:AIG) retreated 4.1 percent after the company reported a drop in its first-quarter operating income due to rising claims costs. American International Group Inc (NYSE:AIG) stock performance was -4.14% in last session and finished the day at $50.54. Traded volume was 21.78million shares in the last session and the average volume of the stock remained 9.33million shares. The beta of the … Continue reading Investor’s Alert: American International Group Inc (NYSE:AIG), General Electric Company (NYSE:GE), Petroleo Brasileiro Petrobras (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

FB Nasdaq FB Facebook

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

A proxy advisory firm has asked shareholders of the Indian unit of Wyeth to oppose its merger deal with Pfizer Inc. (NYSE:PFE) as the share swap ratio is skewed in favour of Pfizer Inc. (NYSE:PFE). Shareholder Empowerment Services (SES) has made this suggestion ahead of the shareholder meeting this week. Pfizer Inc. (NYSE:PFE) stock performance was 0.07% in last session and finished the day at … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

Healthcare Active Runners: Gilead Sciences (NASDAQ:GILD), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), MannKind Corporation (NASDAQ:MNKD)

Gilead Sciences, Inc. (NASDAQ:GILD) announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi(R) (sofosbuvir) 400 mg was administered for the treatment of chronic hepatitis C virus (HCV) infection in patients with advanced liver disease. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was -7.32% in last session and finished the day at $65.48. Traded volume was 43.15million … Continue reading Healthcare Active Runners: Gilead Sciences (NASDAQ:GILD), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), MannKind Corporation (NASDAQ:MNKD)

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)

During the trial, palbociclib — a pill — was combined with the standard anti-estrogen treatment Letrozole. The combined treatment resulted in a 26.1 month progression-free survival rate compared with only 7.5 months for Letrozole alone. Under development by Pfizer Inc. (NYSE:PFE), the medication used in the study is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6. Pfizer Inc. (NYSE:PFE) stock performance was -1.06% … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)